Skip to content

Evaluation of the effects of an AI-based sleep service

Effects of an AI-based sleep service on sleep among workers - Effects of an AI-based sleep service on sleep among workers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061291
Enrollment
35
Registered
2026-04-20
Start date
2026-05-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Participants will use an AI-based sleep service that provides: 1) personalized behavioral recommendations tailored to regular shift cycles and transitions
2) weekly AI-generated feedback based on these recommendations
3) automated data-entry reminders
and 4) AI-powered Q&amp
A support and assistance with data interpretation. No intervention

Sponsors

EUPHORIA Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy men and women aged 18 years or older. 2. Employees of a company (including both day-shift and shift workers). 3. Shift workers with a regular rotating shift schedule.

Exclusion criteria

Exclusion criteria: 1. Individuals who have difficulty operating computers or smartphones at a level comparable to healthy individuals. 2. Individuals who participated in another clinical trial within the past month, or plan to participate in other clinical research after providing consent for this study. 3. Individuals with a history of, or current, serious diseases (e.g., diabetes, liver disease, kidney disease, heart disease, or cardiovascular disease). 4. Individuals currently receiving medical treatment for any disease, or those with a history of serious illness requiring medication. 5. Individuals unable to refrain from starting new use of health foods (including supplements affecting the cardiovascular system or metabolism), quasi-drugs, over-the-counter (OTC) drugs, or external analgesics/anti-inflammatory agents (such as poultices) during the study period. 6. Others judged ineligible for the study by their primary physician or the principal investigator.

Design outcomes

Primary

MeasureTime frame
The Athens Insomnia Scale

Secondary

MeasureTime frame
<Secondary Outcomes> The Japanese version of the Epworth Sleepiness Scale Subjective sleep restfulness Presenteeism <Secondary Outcomes: Daily during the intervention period (Intervention group only)> Work shift (from last night to this morning) Daily sleep duration (Bedtime and Wake-up time) Subjective satisfaction with physical condition <Eligibility Confirmation / Participant Characteristics> Age (Date of birth), Sex Years of continuous work / Employment duration Family composition Lifestyle and behavioral habits Dietary patterns (Proportion of breakfast, lunch, and dinner) Medication status Sleep-related concerns/problems

Countries

Japan

Contacts

Public ContactSawa Kato

EUPHORIA Co., Ltd. Corporate Business Division

sawa.kato@eu-phoria.jp050-1744-7921

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026